Literature DB >> 22909329

Commentary.

J Nicholls1.   

Abstract

Mesh：

Year:  2012        PMID： 22909329     DOI： 10.1111/j.1463-1318.2012.03162.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN： 1462-8910            Impact factor:   3.788


× No keyword cloud information.
  2 in total

1.  The optimal indication for FiLaC® is high trans-sphincteric fistula-in-ano: a prospective cohort of 69 consecutive patients.

Authors:  I Marref; L Spindler; M Aubert; N Lemarchand; N Fathallah; E Pommaret; D Soudan; H Pillant-le Moult; E Safa Far; K Fellous; E Crochet; B Mory; P Benfredj; V de Parades
Journal:  Tech Coloproctol       Date:  2019-09-26       Impact factor: 3.781

2.  Role of specific DNA mutations in the peripheral blood of colorectal cancer patients for the assessment of tumor stage and residual disease following tumor resection.

Authors:  Gregor Norcic; Franc Jelenc; Petra Cerkovnik; Vida Stegel; Srdjan Novakovic
Journal:  Oncol Lett       Date:  2016-09-01       Impact factor: 2.967
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.